Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.35 |
| ▸ | ANPEP | P15144 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | ALPI | P09923 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | XIAP | P98170 | 1/20 | 0.34 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27300743 | 0.83 | EPHX1 (0.50) | EPHX1TAAR1SLC6A2SIGMAR1MAOA | |
| Ammonia Solution, Strong SCHEMBL29283276 | 0.81 | EPHX1 (0.48) | EPHX1TAAR1SLC6A2SIGMAR1MAOA | |
| SCHEMBL28177028 | 0.78 | TAAR1 (0.37) | EPHX1TAAR1SLC6A2SIGMAR1MAOA | |
| SCHEMBL353629 | 0.75 | EPHX1 (0.48) | EPHX1TAAR1SLC6A2SIGMAR1MAOA | |
| SCHEMBL22499343 | 0.75 | EPHX1 (0.43) | EPHX1TAAR1SLC6A2SIGMAR1MAOA | |
| SCHEMBL3883482 | 0.75 | EPHX1 (0.43) | EPHX1TAAR1SLC6A2SIGMAR1MAOA | |
| SCHEMBL28573244 | 0.75 | TRPA1 (0.50) | EPHX1TAAR1SLC6A2SIGMAR1MAOA | |
| SCHEMBL11821207 | 0.75 | TRPA1 (0.47) | EPHX1TAAR1SLC6A2SIGMAR1MAOA | |
| SCHEMBL27660444 | 0.75 | TRPA1 (0.50) | EPHX1TAAR1SLC6A2SIGMAR1MAOA | |
| SCHEMBL4981467 | 0.72 | EPHX1 (0.60) | EPHX1TAAR1SLC6A2SIGMAR1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1985645-B1 | Low molecular weight siloxanes with one functional group | GELEST INC (US) | 2017-03-15 | — | — | EP | disclosed |
| US-9528019-B2 | Ultraviolet-curable inkjet composition and material | SEIKO EPSON CORPORATION (JP) | 2016-12-27 | — | — | US | disclosed |
| US-20160272833-A1 | ULTRAVIOLET-CURABLE INKJET COMPOSITION AND MATERIAL | SEIKO EPSON CORPORATION (JP) | 2016-09-22 | — | — | US | disclosed |
| US-9422442-B2 | Material including print layer produced by ultraviolet-curable composition | SEIKO EPSON CORPORATION (JP) | 2016-08-23 | — | — | US | disclosed |
| US-9416288-B2 | Inkjet recording method | SEIKO EPSON CORPORATION (JP) | 2016-08-16 | — | — | US | disclosed |
| US-9382443-B2 | Metal powder, ultraviolet-curable inkjet composition and recording material | SEIKO EPSON CORPORATION (JP) | 2016-07-05 | — | — | US | disclosed |
| WO-2016067584-A1 | METHOD FOR MANUFACTURING THREE-DIMENSIONAL STRUCTURE, THREE-DIMENSIONAL STRUCTURE MANUFACTURING APPARATUS, AND THREE-DIMENSIONAL STRUCTURE | SEIKO EPSON CORPORATION (JP) | 2016-05-06 | — | — | WO | disclosed |
| US-20160009933-A1 | MATERIAL INCLUDING PRINT LAYER PRODUCED BY ULTRAVIOLET-CURABLE COMPOSITION | SEIKO EPSON CORPORATION (JP) | 2016-01-14 | — | — | US | disclosed |
| US-9080069-B2 | Composition for inkjet and recording material | SEIKO EPSON CORPORATION (JP) | 2015-07-14 | — | — | US | disclosed |
| US-20150145935-A1 | INKJET RECORDING METHOD | SEIKO EPSON CORPORATION (JP) | 2015-05-28 | — | — | US | disclosed |
| US-20100298591-A1 | ASYMMETRIC LOW MOLECULAR WEIGHT SILOXANES WITH ONE FUNCTIONAL GROUP | GELEST, INC. (US) | 2010-11-25 | — | — | US | disclosed |
| US-7799888-B2 | Low molecular weight siloxanes with one functional group | GELEST, INC. (US) | 2010-09-21 | — | — | US | disclosed |
| EP-1428795-B1 | SILSESQUIOXANE DERIVATIVES AND PROCESS FOR PRODUCTION THEREOF | CHISSO CORP (JP) | 2009-07-22 | — | — | EP | disclosed |
| US-7449539-B2 | Silsesquioxane derivative and production process for the same | CHISSO CORPORATION (JP) | 2008-11-11 | — | — | US | disclosed |
| US-20080269429-A1 | LOW MOLECULAR WEIGHT SILOXANES WITH ONE FUNCTIONAL GROUP | GELEST, INC. (US) | 2008-10-30 | — | — | US | disclosed |
| EP-1985645-A2 | Low molecular weight siloxanes with one functional group | GELEST, INC. (US) | 2008-10-29 | — | — | EP | disclosed |
| US-20070032454-A1 | Silsesquioxane derivative and production process for the same | JNC CORPORATION (JP) | 2007-02-08 | — | — | US | disclosed |
| US-7169873-B2 | Silsesquioxane derivatives and process for production thereof | CHISSO CORPORATION (JP) | 2007-01-30 | — | — | US | disclosed |
| US-20040249103-A1 | Silsesquioxane derivatives and process for production thereof | JNC CORPORATION (JP) | 2004-12-09 | — | — | US | disclosed |
| EP-1428795-A1 | SILSESQUIOXANE DERIVATIVES AND PROCESS FOR PRODUCTION THEREOF | CHISSO CORPORATION (JP) | 2004-06-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298591-A1 | ASYMMETRIC LOW MOLECULAR WEIGHT SILOXANES WITH ONE FUNCTIONAL GROUP | ILK, LASP1, PCNA | EPHX1 2370/4885TAAR1 3400/4885SLC6A2 4765/4885 |
| US-20070032454-A1 | Silsesquioxane derivative and production process for the same | KCNQ1, KCNQ2, KCNQ5 | EPHX1 145/4885TAAR1 2908/4885SLC6A2 2885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.